The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 23 , ISSUE 11 ( November, 2022 ) > List of Articles


Assessing the Potential Applications of Epidrugs in Epigenetic-mediated Head and Neck Squamous Cell Carcinoma

V Vishnu Priya, Y Dinesh, Vishnu Priya Veeraraghavan, A Thirumal Raj

Citation Information : Priya VV, Dinesh Y, Veeraraghavan VP, Raj AT. Assessing the Potential Applications of Epidrugs in Epigenetic-mediated Head and Neck Squamous Cell Carcinoma. J Contemp Dent Pract 2022; 23 (11):1077-1078.

DOI: 10.5005/jp-journals-10024-3347

License: CC BY-NC 4.0

Published Online: 17-03-2023

Copyright Statement:  Copyright © 2022; The Author(s).


  1. Bhusan B. Head and Neck Cancer: A Comprehensive Review of Head and Neck Squamous Cell Carcinoma. 2019. pp. 1–150.
  2. Ravikumar D, Gurunathan D, Gayathri R, et al. DNA profiling of Streptococcus mutans in children with and without black tooth stains: A polymerase chain reaction analysis. Dent Res J (Isfahan) 15(5):334–339. PMID: 30233653.
  3. Castilho R, Squarize C, Almeida L. Epigenetic modifications and head and neck cancer: Implications for tumor progression and resistance to therapy. Int J Mol Sci 2017;18(7):1506. DOI: 10.3390/ijms18071506.
  4. Lim Y, Sun CX, Tran P, et al. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas. Biomark Med 2016;10:301–313. DOI: 10.2217/bmm.16.2.
  5. Radhakrishnan R, Kabekkodu S, Satyamoorthy K. DNA hypermethylation as an epigenetic mark for oral cancer diagnosis. J Oral Pathol Med 2011;40:665–676. DOI: 10.1111/j.1600-0714.2011.01055.x.
  6. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358(11):1148–1159. DOI: 10.1056/NEJMra072067.
  7. Shridhar K, Walia GK, Aggarwal A, et al. DNA methylation markers for oral pre-cancer progression: A critical review. Oral Oncol 2016;53:1–9. DOI: 10.1016/j.oraloncology.2015.11.012.
  8. Romanowska K, Sobecka A, Rawłuszko–Wieczorek AA, et al. Head and neck squamous cell carcinoma: Epigenetic landscape. Diagnostics 2020;11(1):34. DOI: 10.3390/diagnostics11010034.
  9. Burkitt K, Saloura V. Epigenetic Modifiers as novel therapeutic targets and a systematic review of clinical studies investigating epigenetic inhibitors in head and neck cancer. Cancers (Basel) 2021;13(20):5241. DOI: 10.3390/cancers13205241.
  10. Janiszewska J, Szaumkessel M, Szyfter K. microRNAs are important players in head and neck carcinoma: A review. Crit Rev Oncol Hematol 2013;88(3):716–728. DOI: 10.1016/j.critrevonc.2013.07.012.
  11. D'Souza W, Saranath D. Clinical implications of epigenetic regulation in oral cancer. Oral Oncol 2015;51(12):1061–1068. DOI: 10.1016/j.oraloncology.2015.09.006.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.